|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:AHR-TSPAN13 (FusionGDB2 ID:3143) |
Fusion Gene Summary for AHR-TSPAN13 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: AHR-TSPAN13 | Fusion gene ID: 3143 | Hgene | Tgene | Gene symbol | AHR | TSPAN13 | Gene ID | 196 | 27075 |
| Gene name | aryl hydrocarbon receptor | tetraspanin 13 | |
| Synonyms | RP85|bHLHe76 | NET-6|NET6|TM4SF13 | |
| Cytomap | 7p21.1 | 7p21.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | aryl hydrocarbon receptorAH-receptorah receptoraromatic hydrocarbon receptorclass E basic helix-loop-helix protein 76 | tetraspanin-13tetraspan NET-6transmembrane 4 superfamily member 13transmembrane 4 superfamily member tetraspan NET-6tspan-13 | |
| Modification date | 20200322 | 20200313 | |
| UniProtAcc | P35869 | . | |
| Ensembl transtripts involved in fusion gene | ENST00000242057, ENST00000492120, | ENST00000466195, ENST00000262067, | |
| Fusion gene scores | * DoF score | 6 X 5 X 5=150 | 7 X 6 X 6=252 |
| # samples | 8 | 9 | |
| ** MAII score | log2(8/150*10)=-0.906890595608519 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(9/252*10)=-1.48542682717024 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: AHR [Title/Abstract] AND TSPAN13 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | AHR(17338953)-TSPAN13(16815836), # samples:3 TSPAN13(16793655)-AHR(17349559), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | AHR-TSPAN13 seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. AHR-TSPAN13 seems lost the major protein functional domain in Hgene partner, which is a transcription factor due to the frame-shifted ORF. AHR-TSPAN13 seems lost the major protein functional domain in Hgene partner, which is a tumor suppressor due to the frame-shifted ORF. AHR-TSPAN13 seems lost the major protein functional domain in Tgene partner, which is a tumor suppressor due to the frame-shifted ORF. TSPAN13-AHR seems lost the major protein functional domain in Hgene partner, which is a tumor suppressor due to the frame-shifted ORF. TSPAN13-AHR seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. TSPAN13-AHR seems lost the major protein functional domain in Tgene partner, which is a transcription factor due to the frame-shifted ORF. TSPAN13-AHR seems lost the major protein functional domain in Tgene partner, which is a tumor suppressor due to the frame-shifted ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | AHR | GO:0006355 | regulation of transcription, DNA-templated | 10395741 |
| Hgene | AHR | GO:0006357 | regulation of transcription by RNA polymerase II | 15681594 |
| Hgene | AHR | GO:0006366 | transcription by RNA polymerase II | 10395741 |
| Hgene | AHR | GO:0009410 | response to xenobiotic stimulus | 7961644 |
| Hgene | AHR | GO:0009636 | response to toxic substance | 7961644 |
| Hgene | AHR | GO:0010468 | regulation of gene expression | 15681594 |
| Hgene | AHR | GO:0019933 | cAMP-mediated signaling | 17329248 |
| Hgene | AHR | GO:0030888 | regulation of B cell proliferation | 15681594 |
| Hgene | AHR | GO:0071320 | cellular response to cAMP | 17329248 |
| Hgene | AHR | GO:1904322 | cellular response to forskolin | 17329248 |
| Hgene | AHR | GO:1904613 | cellular response to 2,3,7,8-tetrachlorodibenzodioxine | 17329248 |
| Fusion gene breakpoints across AHR (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene breakpoints across TSPAN13 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | BLCA | TCGA-XF-A9T0-01A | AHR | chr7 | 17338953 | - | TSPAN13 | chr7 | 16815836 | + |
| ChimerDB4 | BLCA | TCGA-XF-A9T0-01A | AHR | chr7 | 17338953 | + | TSPAN13 | chr7 | 16815836 | + |
| ChimerDB4 | BLCA | TCGA-XF-A9T0 | AHR | chr7 | 17338953 | + | TSPAN13 | chr7 | 16815835 | + |
| ChimerDB4 | BLCA | TCGA-XF-A9T0 | AHR | chr7 | 17338953 | + | TSPAN13 | chr7 | 16815836 | + |
| ChimerDB4 | HNSC | TCGA-CV-5436-01A | AHR | chr7 | 17349747 | + | TSPAN13 | chr7 | 16823042 | + |
Top |
Fusion Gene ORF analysis for AHR-TSPAN13 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-3UTR | ENST00000242057 | ENST00000466195 | AHR | chr7 | 17338953 | + | TSPAN13 | chr7 | 16815836 | + |
| 5CDS-3UTR | ENST00000242057 | ENST00000466195 | AHR | chr7 | 17338953 | + | TSPAN13 | chr7 | 16815835 | + |
| 5CDS-intron | ENST00000242057 | ENST00000466195 | AHR | chr7 | 17349747 | + | TSPAN13 | chr7 | 16823042 | + |
| Frame-shift | ENST00000242057 | ENST00000262067 | AHR | chr7 | 17338953 | + | TSPAN13 | chr7 | 16815836 | + |
| Frame-shift | ENST00000242057 | ENST00000262067 | AHR | chr7 | 17338953 | + | TSPAN13 | chr7 | 16815835 | + |
| Frame-shift | ENST00000242057 | ENST00000262067 | AHR | chr7 | 17349747 | + | TSPAN13 | chr7 | 16823042 | + |
| intron-3CDS | ENST00000492120 | ENST00000262067 | AHR | chr7 | 17338953 | + | TSPAN13 | chr7 | 16815836 | + |
| intron-3CDS | ENST00000492120 | ENST00000262067 | AHR | chr7 | 17338953 | + | TSPAN13 | chr7 | 16815835 | + |
| intron-3CDS | ENST00000492120 | ENST00000262067 | AHR | chr7 | 17349747 | + | TSPAN13 | chr7 | 16823042 | + |
| intron-3UTR | ENST00000492120 | ENST00000466195 | AHR | chr7 | 17338953 | + | TSPAN13 | chr7 | 16815836 | + |
| intron-3UTR | ENST00000492120 | ENST00000466195 | AHR | chr7 | 17338953 | + | TSPAN13 | chr7 | 16815835 | + |
| intron-intron | ENST00000492120 | ENST00000466195 | AHR | chr7 | 17349747 | + | TSPAN13 | chr7 | 16823042 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for AHR-TSPAN13 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| AHR | chr7 | 17349747 | + | TSPAN13 | chr7 | 16823041 | + | 7.02E-05 | 0.9999298 |
| AHR | chr7 | 17338953 | + | TSPAN13 | chr7 | 16815835 | + | 2.45E-07 | 0.99999976 |
| AHR | chr7 | 17338953 | + | TSPAN13 | chr7 | 16815835 | + | 2.45E-07 | 0.99999976 |
| AHR | chr7 | 17349747 | + | TSPAN13 | chr7 | 16823041 | + | 7.02E-05 | 0.9999298 |
| AHR | chr7 | 17338953 | + | TSPAN13 | chr7 | 16815835 | + | 2.45E-07 | 0.99999976 |
| AHR | chr7 | 17338953 | + | TSPAN13 | chr7 | 16815835 | + | 2.45E-07 | 0.99999976 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
 |
Top |
Fusion Protein Features for AHR-TSPAN13 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:17338953/:16815836) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| AHR | . |
| FUNCTION: Ligand-activated transcription factor that enables cells to adapt to changing conditions by sensing compounds from the environment, diet, microbiome and cellular metabolism, and which plays important roles in development, immunity and cancer (PubMed:30373764, PubMed:23275542, PubMed:7961644, PubMed:32818467). Upon ligand binding, translocates into the nucleus, where it heterodimerizes with ARNT and induces transcription by binding to xenobiotic response elements (XRE) (PubMed:30373764, PubMed:23275542, PubMed:7961644). Regulates a variety of biological processes, including angiogenesis, hematopoiesis, drug and lipid metabolism, cell motility and immune modulation (PubMed:12213388). Xenobiotics can act as ligands: upon xenobiotic-binding, activates the expression of multiple phase I and II xenobiotic chemical metabolizing enzyme genes (such as the CYP1A1 gene) (PubMed:7961644). Mediates biochemical and toxic effects of halogenated aromatic hydrocarbons (PubMed:7961644). Next to xenobiotics, natural ligands derived from plants, microbiota, and endogenous metabolism are potent AHR agonists (PubMed:18076143). Tryptophan (Trp) derivatives constitute an important class of endogenous AHR ligands (PubMed:32866000, PubMed:32818467). Acts as a negative regulator of anti-tumor immunity: indoles and kynurenic acid generated by Trp catabolism act as ligand and activate AHR, thereby promoting AHR-driven cancer cell motility and suppressing adaptive immunity (PubMed:32818467). Regulates the circadian clock by inhibiting the basal and circadian expression of the core circadian component PER1 (PubMed:28602820). Inhibits PER1 by repressing the CLOCK-ARNTL/BMAL1 heterodimer mediated transcriptional activation of PER1 (PubMed:28602820). The heterodimer ARNT:AHR binds to core DNA sequence 5'-TGCGTG-3' within the dioxin response element (DRE) of target gene promoters and activates their transcription (PubMed:28602820). {ECO:0000269|PubMed:23275542, ECO:0000269|PubMed:28602820, ECO:0000269|PubMed:30373764, ECO:0000269|PubMed:32818467, ECO:0000269|PubMed:32866000, ECO:0000269|PubMed:7961644, ECO:0000303|PubMed:12213388, ECO:0000303|PubMed:18076143}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for AHR-TSPAN13 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
Top |
Fusion Gene PPI Analysis for AHR-TSPAN13 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for AHR-TSPAN13 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for AHR-TSPAN13 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies